上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1354Please respect copyright.PENANAJXBpbXbBlu
1354Please respect copyright.PENANANL2Bwe58HF
上集:https://www.penana.com/article/4711251354Please respect copyright.PENANA5n1wWpLDWw
1354Please respect copyright.PENANAcswYDc6qcV1354Please respect copyright.PENANAjRWQTgL7LE
1354Please respect copyright.PENANA4d43tTa2Vl
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1354Please respect copyright.PENANAS5D5OpmWAQ
1354Please respect copyright.PENANANiV90vBEpX
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1354Please respect copyright.PENANASJrYeaoHgl
1354Please respect copyright.PENANAFDhy3AXUCe
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1354Please respect copyright.PENANA2QH23WFKru
1354Please respect copyright.PENANA3VRdOzHvYy1354Please respect copyright.PENANAFX1k9x9QWR
1354Please respect copyright.PENANAuYKd1P6HEZ
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1354Please respect copyright.PENANAYsEXrf4eB3
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1354Please respect copyright.PENANAri2PERpc86
1354Please respect copyright.PENANAEXlDb0A7QE
忘記甚麼是Neoantigen的話,可重溫上一集。1354Please respect copyright.PENANAYdbxGnY8oA
1354Please respect copyright.PENANAS5uSgCvB0G
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1354Please respect copyright.PENANAuDeisKS2Ya
1354Please respect copyright.PENANA1maNf2EAdW
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1354Please respect copyright.PENANAJWgfM9Zyr2
1354Please respect copyright.PENANA3lfvEYfsjk1354Please respect copyright.PENANAtFtf2BATIS
1354Please respect copyright.PENANAFtGElTjLks
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1354Please respect copyright.PENANAxXi6sGSMQk
1354Please respect copyright.PENANA7Ucs2FR3El
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1354Please respect copyright.PENANArUMJw0B2Sn
1354Please respect copyright.PENANAvvsBro7fTf
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1354Please respect copyright.PENANABVyuKQnIWw1354Please respect copyright.PENANAqqdctniKWN
1354Please respect copyright.PENANAub0seUTR6v
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1354Please respect copyright.PENANAxgfNYihxi8
1354Please respect copyright.PENANA7ckjlJRt1p
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1354Please respect copyright.PENANAOtVTVnRaIi1354Please respect copyright.PENANAbsRmnXRXvj
1354Please respect copyright.PENANAD7XTH6Cncl
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1354Please respect copyright.PENANAKru3gGgiR3
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1354Please respect copyright.PENANAPcKzTVLiho
1354Please respect copyright.PENANAMtB7q9AcRD
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1354Please respect copyright.PENANAVpp6CEqUBO
1354Please respect copyright.PENANA1Ui5Wr0yKp
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1354Please respect copyright.PENANA9dTBdkiQfh
1354Please respect copyright.PENANAXg0CFDTwDn
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1354Please respect copyright.PENANAYoNRABfUvX
1354Please respect copyright.PENANAFVZRJz6yYH
1354Please respect copyright.PENANAClw3rn8ytS
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1354Please respect copyright.PENANAnjpps6LG6j
1354Please respect copyright.PENANAzijt0uU0bc
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1354Please respect copyright.PENANAT6kIfACKHu
1354Please respect copyright.PENANAIKjHHVsnGp
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1354Please respect copyright.PENANAjCUcWwOU8F
1354Please respect copyright.PENANAZgvhEgLrab
Link:1354Please respect copyright.PENANA3BpnXwKCHt
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1354Please respect copyright.PENANAYGAYoshfGZ
1354Please respect copyright.PENANAGfX1PSAuUd
1354Please respect copyright.PENANArxF1oauQKw
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1354Please respect copyright.PENANAHrZLaidr5u